1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
65.60%
Positive revenue growth while WEED.TO is negative. John Neff might see a notable competitive edge here.
109.55%
Positive gross profit growth while WEED.TO is negative. John Neff would see a clear operational edge over the competitor.
77.73%
Positive EBIT growth while WEED.TO is negative. John Neff might see a substantial edge in operational management.
77.73%
Positive operating income growth while WEED.TO is negative. John Neff might view this as a competitive edge in operations.
115.00%
Net income growth under 50% of WEED.TO's 477.69%. Michael Burry would suspect the firm is falling well behind a key competitor.
115.13%
EPS growth under 50% of WEED.TO's 460.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
114.87%
Diluted EPS growth under 50% of WEED.TO's 460.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.41%
Share reduction more than 1.5x WEED.TO's 0.86%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.04%
Diluted share reduction more than 1.5x WEED.TO's 4.37%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
14.93%
Positive OCF growth while WEED.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
21.35%
FCF growth above 1.5x WEED.TO's 9.95%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1088.27%
3Y revenue/share CAGR above 1.5x WEED.TO's 243.16%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-5491.93%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-3771.73%
Negative 5Y OCF/share CAGR while WEED.TO is at 79.99%. Joel Greenblatt would question the firm’s operational model or cost structure.
-1815.90%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
1243.82%
Below 50% of WEED.TO's 13427.57%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
413.21%
5Y net income/share CAGR above 1.5x WEED.TO's 179.38%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
272.91%
Below 50% of WEED.TO's 1110.46%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
5974.97%
10Y equity/share CAGR in line with WEED.TO's 5919.93%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
13212.67%
Positive 5Y equity/share CAGR while WEED.TO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
1278.80%
3Y equity/share CAGR above 1.5x WEED.TO's 270.56%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
27.87%
Our AR growth while WEED.TO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
3.14%
We show growth while WEED.TO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
15.58%
Positive asset growth while WEED.TO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-2.05%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
513.53%
Debt growth far above WEED.TO's 12.20%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
14.17%
We increase R&D while WEED.TO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-22.82%
We cut SG&A while WEED.TO invests at 23.71%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.